Although further research is needed, Spravato provides a new treatment avenue for patients with TRD
We adjusted for patient age, sex, race, ethnicity, Social Vulnerability Index quintile, starting BMI, weight change after treatment, history of insulin usage, and starting HbA1c
Distinguishing between symptoms related to post-cholecystectomy digestive changes and those attributable to tirzepatide can be challenging, particularly during the initial titration period when gastrointestinal side effects are most common
Clostridium diggicile associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including azithromycin for injection, and may range in everity from mild diarrhea to fatal colitis